N-(4-methylthio-phenyl)-4-fluorobenzamidine

• 分子结构分类: 有机化合物 - 有机硫化合物 - 硫醚类
• 英文名称: N-(4-methylthio-phenyl)-4-fluorobenzamidine
• 英文别名: 4-fluoro-N'-(4-methylsulfanylphenyl)benzenecarboximidamide
• 化学式: C₁₄H₁₃FN₂S
• 分子量: 260.335
• InChiKey: UQFVKEORZCWBIV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  18
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  63.7
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  N-(4-methylthio-phenyl)-4-fluorobenzamidine 、 3,3-双(甲硫基)-2-氰基丙烯酸乙酯 以81.8%的产率得到5-Cyano-2-(4-fluorophenyl)-1-(4-methylthio-phenyl)-4-methylthio-1,6-dihydro-pyrimidin-6-one
  参考文献：
  名称：

  Novel pyrimidone derivatives

  摘要：

  本发明涉及一般式（I）的新型嘧啶酮衍生物，它们的衍生物、类似物、互变异构体、立体异构体、多晶形态、水合物、溶剂合物、药学上可接受的盐以及含有它们的药学上可接受的组合物。本发明更具体地提供了一般式（I）的新型嘧啶酮衍生物及其制备方法。

  公开号：

  US20030225075A1
• 作为产物：
  描述：

  对氟苯腈 、 4-氨基茴香硫醚 生成 N-(4-methylthio-phenyl)-4-fluorobenzamidine
  参考文献：
  名称：

  Novel pyrimidon derivatives

  摘要：

  本发明涉及一种新的嘧啶酮，其通式为（I），其衍生物，类似物，互变异构体，立体异构体，多晶形态，水合物，溶剂化物，药学上可接受的盐以及包含它们的药学上可接受的组合物。本发明更具体地涉及一种新的嘧啶酮，其通式为（I）。

  公开号：

  US20040259891A1

文献信息

• Novel pyrimidon derivatives
  申请人：Orchid Chemical & Pharmaceuticals Limited

  公开号：US20040259891A1

  公开（公告）日：2004-12-23

  The present invention relates to novel pyrimidones of the general formula (I), their derivatives, their analogs, their tautomeric forms, their stereoisomers, their polymorphs, their hydrates, their solvates, their pharmaceutically acceptable salts and pharmaceutically acceptable compositions containing them. The present invention more particularly novel pyrimidones of the general formula (I). 1

  本发明涉及一种新的嘧啶酮，其通式为(I)，它们的衍生物、类似物、互变异构体、立体异构体、多晶形态、水合物、溶剂合物、药用盐及含有它们的药用成分。本发明更具体地涉及通式(I)的新嘧啶酮。
• PYRIMIDONE DERIVATIVES USEFUL FOR THE TREATMENT OF INFLAMMATION AND IMMUNOLOGICAL DISEASES
  申请人：Orchid Chemicals and Pharmaceuticals Ltd

  公开号：EP1492774A2

  公开（公告）日：2005-01-05
• US7365069B2
  申请人：——

  公开号：US7365069B2

  公开（公告）日：2008-04-29
• [EN] NOVEL PYRIMIDONE DERIVATIVES<br/>[FR] NOUVEAUX DERIVES DE PYRIMIDONE
  申请人：ORCHID CHEMICALS & PHARM LTD

  公开号：WO2003084938A2

  公开（公告）日：2003-10-16

  AbstractThe present invention relates to novel pyrimidone derivatives of the general formula (I), their derivatives, their analogs, their tautomeric forms, their stereoisomers, their polymorphs, their hydrates, their solvates, their pharmaceutically acceptable salts and pharmaceutically acceptable compositions containing them. The present invention more particularly provides novel pyrimidone derivatives of the general formula (I).
• Novel pyrimidone derivatives
  申请人：Orchid Chemicals & Pharmaceuticals Limited

  公开号：US20030225075A1

  公开（公告）日：2003-12-04

  The present invention relates to novel pyrimidone derivatives of the general formula (I), their derivatives, their analogs, their tautomeric forms, their stereoisomers, their polymorphs, their hydrates, their solvates, their pharmaceutically acceptable salts and pharmaceutically acceptable compositions containing them. The present invention more particularly provides novel pyrimidone derivatives of the general formula (I) and a method thereof. 1

  本发明涉及一般式（I）的新型嘧啶酮衍生物，它们的衍生物、类似物、互变异构体、立体异构体、多晶形态、水合物、溶剂合物、药学上可接受的盐以及含有它们的药学上可接受的组合物。本发明更具体地提供了一般式（I）的新型嘧啶酮衍生物及其制备方法。